文献速递胰腺与胆道疾病消化内镜

超声内镜引导下胆道引流与经皮胆道引流在ERCP失败时的疗效与安全性比较:系统评价与荟萃分析

Efficacy and safety of EUS-guided biliary drainage in comparison with percutaneous biliary drainage when ERCP fails: a systematic review and meta-analysis.
PubMed 文献 · Gastrointest Endosc · 2017-01-04

该系统评价与荟萃分析检索多个数据库至2016年9月4日,纳入9项对照研究共483例患者,比较ERCP失败后超声内镜引导下胆道引流(EUS-BD)与经皮经肝胆道引流(PTBD)的疗效与安全性。结果显示EUS-BD临床成功率更高、术后不良事件更少、再干预率更低,但住院时间无差异,成本效益分析受异质性限制。作者认为在具备先进内镜技术和条件时可优先考虑EUS-BD。

要点

  • EUS-BD与PTBD技术成功率无显著差异(OR 1.78,95%CI 0.69-4.59)。
  • EUS-BD临床成功率更高(OR 0.45,95%CI 0.23-0.89)。
  • EUS-BD术后不良事件更少(OR 0.23,95%CI 0.12-0.47)且再干预率更低(OR 0.13,95%CI 0.07-0.24)。

核心结论

  • ERCP胆道引流失败时,若具备足够的先进内镜专业技术和条件,EUS引导下干预可能优于PTBD。
  • EUS-BD与更高的临床成功率、更低的术后不良事件率和更少的再干预相关。

研究设计与样本

  • 系统评价与荟萃分析,检索多个数据库自建库至2016年9月4日,纳入比较EUS-BD与PTBD疗效和安全性的对照研究。
  • 最终纳入9项研究共483例患者。
  • 分类变量计算比值比(OR),连续变量计算标准均数差,采用随机效应模型进行荟萃分析。

主要发现

  • 技术成功率两组无差异(OR 1.78,95%CI 0.69-4.59;I²=22%)。
  • EUS-BD临床成功率更优(OR 0.45,95%CI 0.23-0.89;I²=0%)。
  • EUS-BD术后不良事件更少(OR 0.23,95%CI 0.12-0.47;I²=57%)。
  • EUS-BD再干预率更低(OR 0.13,95%CI 0.07-0.24;I²=0%)。
  • 住院时间两组无差异(合并标准均数差-0.48,95%CI -1.13至0.16),EUS-BD成本效益更优(合并标准均数差-0.63,95%CI -1.06至-0.20),但后两项分析受显著异质性限制。

临床怎么用

  • 作者认为,ERCP失败时若具备足够的先进内镜专业技术和条件,EUS引导下干预可能优于PTBD。

局限性

  • 住院时间和成本效益分析受显著异质性限制。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: EUS-guided biliary drainage (EUS-BD) is increasingly used as an alternate therapeutic modality to percutaneous transhepatic biliary drainage (PTBD) for biliary obstruction in patients who fail ERCP. We conducted a systematic review and meta-analysis to compare the efficacy and safety of these 2 procedures. METHODS: We searched several databases from inception to September 4, 2016 to identify comparative studies evaluating the efficacy and safety of EUS-BD and PTBD. Primary outcomes of interest were the differences in technical success and postprocedure adverse events. Secondary outcomes of interest included clinical success, rate of reintervention, length of hospital stay, and cost comparison for these 2 procedures. Odds ratios (ORs) and standard mean difference were calculated for categorical and continuous variables, respectively. These were analyzed using random effects model of meta-analysis. RESULTS: Nine studies with 483 patients were included in the final analysis. There was no difference in technical success between 2 procedures (OR, 1.78; 95% CI, .69-4.59; I2 = 22%) but EUS-BD was associated with better clinical success (OR, .45; 95% CI, .23-.89; I2 = 0%), fewer postprocedure adverse events (OR, .23; 95% CI, .12-.47; I2 = 57%), and lower rate of reintervention (OR, .13; 95% CI, .07-.24; I2 = 0%). There was no difference in length of hospital stay after the procedures, with a pooled standard mean difference of -.48 (95% CI, -1.13 to .16), but EUS-BD was more cost-effective, with a pooled standard mean difference of -.63 (95% CI, -1.06 to -.20). However, the latter 2 analyses were limited by considerable heterogeneity. CONCLUSIONS: When ERCP fails to achieve biliary drainage, EUS-guided interventions may be preferred over PTBD if adequate advanced endoscopy expertise and logistics are available. EUS-BD is associated with significantly better clinical success, lower rate of postprocedure adverse events, and fewer reinterventions.

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Sharaiha RZ, Khan MA, Kamal F, et al. Efficacy and safety of EUS-guided biliary drainage in comparison with percutaneous biliary drainage when ERCP fails: a systematic review and meta-analysis. Gastrointest Endosc. 2017. PMID: 28063840. doi:10.1016/j.gie.2016.12.023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。